• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Withaferin A

Withaferin A

Product ID W3576
Cas No. 5119-48-2
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $90.20 In stock
5 mg $270.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Withaferin A is a steroid lactone initially produced by Withania somnifera that exhibits anticancer chemotherapeutic, chemopreventive, and anti-inflammatory activities. Withaferin A inhibits vimentin, an intermediate filament, preventing breast cancer cell growth in vitro and in vivo. Withaferin A also increases phosphorylation of JNK, ERK, and p38 MAPK and increases levels of Mcl-1, inducing apoptosis in other in vitro models of breast cancer. Across other breast cancer cell lines, withaferin A increases activation of p53, downregulates expression of ERα, and activates Notch2 and Notch4, inhibiting cellular migration and growth. In ovarian cancer cells, withaferin A downregulates expression of Notch1, Notch3, chc25C, Akt, and Bcl-2, inhibiting growth and colony formation. Withaferin A also inhibits tumor growth of pancreatic xenografts in vivo through ATP-independent inhibition of heat shock protein 90 (HSP90). Additionally, this compound inhibits phosphorylation of IκB kinase, activation of NF-κB, and decreases levels of NO and iNOS in vitro.

Product Info

Cas No.

5119-48-2

Purity

≥98%

Formula

C28H38O6

Formula Wt.

470.6

IUPAC Name

(1S,2R,6S,7R,9R,11S,12S,15R,16S)-6-hydroxy-15-[(1S)-1-[(2R)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one

Melting Point

241-245°C

Solubility

Methanol, Ethanol, DMSO

Appearance

White Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

W3576 MSDS PDF

Info Sheet

W3576 Info Sheet PDF

References

Antony ML, Lee J, Hahm ER, et al. Growth Arrest by the Antitumor Steroidal Lactone Withaferin A in Human Breast Cancer Cells Is Associated with Downregulation and Covalent Binding at Cysteine-303 of β-Tubulin. J Biol Chem. 2013 Dec 2. [Epub ahead of print]. PMID: 24297176.

Hahm ER, Lee J, Singh SV. Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells. Mol Carcinog. 2013 Sep 9. [Epub ahead of print]. PMID: 24019090.

Lee J, Sehrawat A, Singh SV. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Breast Cancer Res Treat. 2012 Nov;136(1):45-56. PMID: 22965833.

Zhang X, Samadi AK, Roby KF, et al. Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A. Gynecol Oncol. 2012 Mar;124(3):606-12. PMID: 22188785.

Hahm ER, Lee J, Huang Y, et al. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells. Mol Carcinog. 2011 Aug;50(8):614-24. PMID: 21432907.

Yu Y, Hamza A, Zhang T, et al. Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol. 2010 Feb 15;79(4):542-51. PMID: 19769945.

Oh JH, Lee TJ, Park JW, et al. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells. Eur J Pharmacol. 2008 Dec 3;599(1-3):11-7. PMID: 18838070.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T7056

    Troglitazone

    Thiazolidinedione; PPARγ agonist, ATP-sensitiv...

    ≥97%
  • R3011

    Recombinant TpN 15 protein

    Recombinant protein containing Treponema pallid...

    ≥95%
  • P3463

    Piperacillin Sodium

    β-lactam; penicillin binding protein inhibitor...

    ≥95%
  • M1646

    Melanin Concentrating Hormone, human/mouse/rat

    Endogenous peptide hormon involved in energy ho...

    ≥98%
  • A0819

    Acetylsalicylic Acid

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • C022692

    Carbinoxamine Maleate

    Histamine H1-antagonist

    ≥98%
  • G7345

    GSK-2606414

    PERK inhibitor.

    ≥99%
  • F1655

    Fenoprofen Calcium Dihydrate

    NSAID; COX-1/2 inhibitor.

    ≥97%
  • S7868

    SRT1720 Hydrochloride

    SIRT 1 activator, SIRT3 inhibitor.

    ≥98%
  • R3577

    Ritonavir

    HIV protease inhibitor.

    ≥98%
  • S0134

    Saikosaponin D

    Triterpene saponin found in Bupleurum.

    ≥98%
  • A0971

    Adrenocorticotropic Hormone (4-10), human

    Endogenous peptide hormone fragment, involved i...

    ≥95%
  • E6256

    Epothilone A

    Microtubule depolymerization inhibitor.

    ≥95%
  • T5769

    Toremifene Base

    SERM, androgen modulator.

    ≥98%
  • G0244

    alpha-Galactosylceramide

    Synthetic glycolipid found in Agelas mauritaniu...

    ≥96%
  • A0960

    Adrenocorticotropic Hormone (1-39), human

    Endogenous peptide hormone, involved in stress ...

    ≥95%
  • S7618

    StemRegenin 1 Hydrochloride

    AhR antagonist.

    ≥98%
  • B5560

    B-type Natriuretic Peptide (1-32), rat

    Endogenous cardiomodulatory peptide; NPR-A agon...

    ≥95%
  • T5720

    Tofacitinib Citrate

    JAK1/2/3 inhibitor.

    ≥99%
  • A2401

    AG-18

    EGFR and PDGFR inhibitor

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only